fashion -WSS

fashion

author：focus 2025-08-04 03:42:44 - browse：429

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Search called off for baby washed away in Pennsylvania flash flood

WSS

What to watch for from Zogenix and Amicus clinical trials

The battle over 'scope creep' and who gets to be called 'doctor'

How to protect coverage of PrEP

What it's like to live with paralysis for one psychologist

Democrats decry new health bill for going easy on private equity

New Alzheimer's drugs heat up race for early detection blood tests

explore

fashion

explore

How one medical school became remarkably diverse

Why patients can’t get everything they want on drug pricing

23andMe had bad news about my health. I wish a person had delivered it

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Continuity nursing helped my family in our darkest PICU moments

New lawsuit accuses health insurer Cigna of denying claims in bulk

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Will the FTC rein in IQVIA's health data empire?

Duchenne breakthrough therapy leaves behind pioneering families

Biogen says it will cut costs by $700 million, slash 1,000 jobs

hotspot

Thousands protest mob assault of women who were paraded naked in remote Indian border state

PrEP can help anyone prevent HIV. Why do so few people take it?

New lawsuit accuses health insurer Cigna of denying claims in bulk

UHS says company favors patients whose insurance pays more

In the gardens at Boston Children's Hospital, families find sanctuary

Device maker Teleflex to acquire urology company for $600M

focus

hotspot

entertainment

hotspot